InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Delaware jury awards Amgen $70m in patent dispute with Hospira

Michael Loney, New York

Amgen has been awarded $70 million in a dispute over a Pfizer subsidiary’s biosimilar of the Epogen treatment for anaemia

A District of Delaware jury has awarded Amgen $70 million in patent damages against Pfizer subsidiary Hospira, in a case before Judge Richard Andrews.

In its verdict, the jury after a five-day trial found infringement of one of the two...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null

Most read articles